$3.41 3.7%
ADPT Stock Price vs. AI Score (Last 150 days)
Data gathered: June 25

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Adaptive Biotechnologies

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Adaptive Biotechnologies
Price $3.41
Target Price Sign up
Volume 527,440
Market Cap $483M
Year Range $2.34 - $5.33
Dividend Yield 0%
Revenue per Employee $204,101
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2439M66M-27M-48M-44M-0.330
Q4 '2343M88M-45M-69M-71M-0.300
Q3 '2334M60M-26M-50M-51M-0.350
Q2 '2345M65M-19M-48M-47M-0.330
Q1 '2334M62M-28M-58M-57M-0.400

Insider Transactions View All

BOBULSKY SUSAN filed to sell 255,265 shares at $3.4.
March 6 '24
BOBULSKY SUSAN filed to sell 248,290 shares at $3.4.
March 6 '24
ROBINS CHAD M filed to sell 2,619,495 shares at $3.4.
March 6 '24
LO FRANCIS filed to sell 253,745 shares at $3.4.
March 6 '24
Taylor Stacy L filed to sell 166,287 shares at $3.4.
March 6 '24

What is the Market Cap of Adaptive Biotechnologies?

The Market Cap of Adaptive Biotechnologies is $483M.

How Many People Work at Adaptive Biotechnologies?

As of our latest update, Adaptive Biotechnologies employed approximately 790 people worldwide. However, it's important to note that Adaptive Biotechnologies' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Adaptive Biotechnologies' revenue per employee?

$204,101. To calculate Adaptive Biotechnologies' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Adaptive Biotechnologies?

Currently, the price of one share of Adaptive Biotechnologies stock is $3.41.

How can I analyze the ADPT stock price chart for investment decisions?

The ADPT stock price chart above provides a comprehensive visual representation of Adaptive Biotechnologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Adaptive Biotechnologies shares. Our platform offers an up-to-date ADPT stock price chart, along with technical data analysis and alternative data insights.

Does ADPT offer dividends to its shareholders?

As of our latest update, Adaptive Biotechnologies (ADPT) does not offer dividends to its shareholders. Investors interested in Adaptive Biotechnologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Adaptive Biotechnologies?

Some of the similar stocks of Adaptive Biotechnologies are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.